-
Monthly diabetes group visits, where patients receive all their recommended tests and examinations in one place, are an effective and cost-efficient way to help diabetics keep their disease under control, but they take a lot of organization, says Donna Zazworsky, RN, MS, CCM, FAAN, manager of network diabetes care, faith community nursing and telemedicine for Carondelet Health Network in Tucson, AZ.
-
Promotoras, or specially trained community health workers, help bridge the gap between members of the community and the medical providers at St. Elizabeth Health Center in Tucson, AZ.
-
When selected Medicare beneficiaries being treated at University of Michigan Health System facilities are discharged from the hospital medical unit or treated and released from the emergency department, case managers at the University of Michigan Faculty Group Practice Medical Management Center call them to make sure they have follow-up appointments and that they understand their treatment plan.
-
A new set of performance measures to increase patient enrollment in cardiac rehabilitation programs and set standards of excellence for program operation were released in 2007.
-
Do you want to know how a health-promoting environment affects your company's bottom line? One new weapon in your arsenal is the Environmental Assessment Tool (EAT).
-
Nearly 5% of employees have high levels of psychological distress associated with a high likelihood of a mental disorder, reports a recent study.1
-
A comprehensive cardiac rehabilitation program is highly beneficial for people who have experienced a cardiac event, such as a heart attack or bypass surgery, says Murray Low, EdD, FAACVPR, FACSM, president-elect of the American Association of Cardiovascular and Pulmonary Rehabilitation.
-
Although research shows that cardiac rehabilitation programs, also known as secondary prevention programs, help improve the health and life expectancy of people with heart conditions, the referral rate is low.
-
-
Concerns about the effects of the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer, New York City; Medroxyprogesterone Acetate Injectable Suspension USP, Teva Pharmaceuticals USA, North Wales, PA) on bone mineral density (BMD) should not prevent clinicians from prescribing the method, nor should its use be limited to two years, according to a new committee opinion released by the American College of Obstetricians and Gynecologists (ACOG).
